Newsroom

新加坡--(BUSINESS WIRE)--(美国商业资讯)-- Black Hat（黑帽大会）是网络安全行业历史最悠久、内容最深入的安全会议系列活动，今天宣布Black Hat Asia 2026的线下部分在新加坡滨海湾金沙展览会议中心顺利收官。来自亚太以及其他地区的安全专业人员齐聚一堂，分享高度实用的情报，涵盖自动网络安全威胁、各自为政的数据保护框架以及保护亚太地区快速数字化的经济所需的防御战略等方面。 主题演讲亮点：重新界定隐私和进攻性自动化 今年的主题演讲嘉宾探索了隐私、主权与可持续安全实践之间不断演变的关系以及自动攻击性安全的兴起： 调查记者Violet Blue质疑有关数据隐私的传统思维：“当我们说到数据时，[自主]到底是什么意思？自主不是‘选择退出’，也不是‘阅读服务条款’。自主是拥有信息、工具以及能做出真实选择的权力，并且这种选择要得到尊重。而看当今人们实际拥有的工具……哪些能实现真正的自主，哪些又不过是隐私游戏？”她的演讲阐述了在亚太地区，传统隐私框架如何变得过时，以及在法规各自为政的时代，可持续的政策应是什么样子。 RunSybil首席执行官兼联合创始人Ari He...

CHICAGO--(BUSINESS WIRE)--Exelon commends an order issued on April 28th by the Federal Energy Regulatory Commission (FERC) that extends the current capacity price collar in PJM. As a part of the recently launched Exelon Promise, the public utility company has been advocating for policy reforms, like the extension of PJM’s capacity price collar, as an essential component of managing energy affordability challenges customers are navigating as efforts to plan for the current and future reliability...

SEATTLE--(BUSINESS WIRE)--MyFreeScoreNow is the first credit monitoring site to offer online access to all three credit bureaus for consumers without social security numbers....

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

SYDNEY--(BUSINESS WIRE)--Enterprises across Asia Pacific are expanding their use of ServiceNow as they adapt to changing geopolitical conditions and the rise of AI, ISG says....

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...

NEW YORK--(BUSINESS WIRE)--KBRA is pleased to announce the assignment of preliminary ratings to eight classes of VMC 2026-FL6, a managed CRE CLO securitization with the ability to reinvest principal proceeds for 30 months. The transaction will initially be collateralized by 16 mortgage loans with an aggregate cutoff date in-trust balance of $852.2 million and $162.5 million of cash collateral for the acquisition of two pre-identified delayed close assets. Additionally, the transaction provides...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as a “biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.” Pertinent to this action is reproxalap, which is a novel reactive aldehyde species (RASP) inhib...

MEXICO CITY--(BUSINESS WIRE)--Industrias Unidas, S.A. de C.V. (“IUSA” or the “Company”) has announced its audited results for the twelve months ended December 31 of 2025. Figures are audited and have been prepared in accordance with Mexican Financial Reporting Standards (“MFRS”), which are different in certain respects from Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). The results from any interim period are not necessarily indicative of the results that may be ex...

READING, Pa.--(BUSINESS WIRE)--Cambridge-Lee Holdings, Inc., has announced its audited consolidated results for the fourth quarter of 2025. CAMBRIDGE-LEE HOLDINGS, INC. AND SUBSIDIARIES (A Wholly Owned Subsidiary of Tubo de Pasteje S.A. de C.V.)   CONSOLIDATED BALANCE SHEETS As of December 31, 2025 and December 31, 2024   Figures in US Dollars 12/31/2024 12/31/2025 Assets Current Assets: Cash and cash equivalents $ 298,409,000     52,585,000   Accounts Receivable - Net   78,187,000     89,869,0...